Related Experiment Videos
[Hyperthyroidism and cancer of the thyroid]
1Service de chirurgie générale, hôpital Saint-Georges, Beyrouth, Liban.
Chirurgie; Memoires De L'Academie De Chirurgie
|January 29, 1999
Summary
Thyrotoxicosis does not prevent thyroid cancer. This study found concurrent thyroid cancer in 8% of hyperthyroid patients, highlighting the need for careful evaluation and management of these cases.
Area of Science:
- Endocrinology
- Oncology
- Surgical Pathology
Background:
- Historically, thyrotoxicosis was considered protective against thyroid cancer.
- Recent literature suggests a frequent association between hyperthyroidism and thyroid cancer.
- This study investigates the incidence and implications of concurrent thyroid cancer in hyperthyroid patients.
Purpose of the Study:
- To report institutional experience with concurrent thyroid cancer in patients with hyperthyroidism.
- To discuss the incidence and consequences of this association based on current data.
Main Methods:
- Retrospective analysis of 734 thyroidectomy patients (January 1983 - January 1998).
- Focus on 125 hyperthyroid patients, identifying 10 with concurrent thyroid cancer (8%).
- Analysis of patient demographics, hyperthyroid etiology (Graves' disease, toxic adenoma, multinodular toxic goiter), cancer characteristics, and surgical management.
Main Results:
- Concurrent thyroid carcinoma was found in 10% of toxic nodular goiter and 4.4% of Graves' disease patients.
- All identified cancers were papillary carcinomas, ranging from 0.2 to 1.5 cm.
- One patient had nodal involvement; no local recurrence or metastasis observed during 1-15 years of follow-up.
Conclusions:
- Hyperthyroidism does not rule out the presence of concurrent thyroid carcinoma.
- The prognostic and therapeutic implications of this association remain subjects of ongoing debate.